CO-RADS, COVID-PCR and prognosis relationship in patients followed in intensive care unit with the diagnosis of COVID-19

ABSTRACT

Introduction: The gold standard method in the diagnosis of COVID-19 is real-time reverse transcriptase-polymerase chain reaction (RT-PCR) however, its sensitivity is reported to be between 42-83% in different studies. Aims and objectives: In this study, we aimed to examine the relationship between CO-RADS levels and prognosis in patients followed in the intensive care unit with the diagnosis of COVID-19. Method(s) All consecutive adult patients with clinically, radiologically, and/or laboratory positive COVID-19 admitted to the Intensive Care Unit between January 2020 and October 2021 were evaluated. Clinical and laboratory data of the patients include characteristics, comorbidities, treatment protocol, respiratory support, hospital stay, RT-PCR status, laboratory test, CO-RADS scores, complications, and prognosis collected from the electronic hospital record system. Result(s) 375 patients were included in the study. In univariate analysis, age, intubation status, serum albumin, CRP, D-dimer, and CO-RADS score were found to be effective variables on mortality. In multivariate analysis, CO-RADS score, and serum albumin levels were found as independent variables affecting mortality (Figure 1). Conclusion(s) This study presents the prognostic value of the CO-RADS classification in patients with COVID-19.